article thumbnail

Lilly to test COVID-19 antibody drug in unorthodox nursing home study

Bio Pharma Dive

Seeking fast answers in a pandemic, Lilly will use mobile RVs to set up infusion clinics at assisted living facilities, which have become COVID-19 hot spots.

Nurses 337
article thumbnail

Phony Diagnoses Hide High Rates of Drugging at Nursing Homes

NY Times

At least 21 percent of nursing home residents are on antipsychotic drugs, a Times investigation found.

Nurses 122
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Lilly's antibody drug prevents COVID-19 in study, but hurdles to use remain

Bio Pharma Dive

Results from a clinical trial in nursing home residents and staff offered the first evidence Lilly's bamlanivimab could protect against, as well as treat, COVID-19

Nurses 281
article thumbnail

U.S. plans crackdown on nursing homes that sedate patients with unnecessary antipsychotics

STAT News

WASHINGTON (AP) — The federal government says it will begin a targeted crackdown on nursing homes’ abuse of antipsychotic drugs and misdiagnoses of schizophrenia in patients.

Nurses 122
article thumbnail

Eli Lilly Claims Drug Prevents Coronavirus Infection in Nursing Homes

NY Times

A monoclonal antibody protected residents and staff members in facilities where the virus had appeared.

Nurses 105
article thumbnail

Drug Prevents Coronavirus Infection in Nursing Homes, Maker Claims

NY Times

A monoclonal antibody protected residents and staff members in facilities where the virus had appeared.

Nurses 98
article thumbnail

Your HCP marketing just became harder, a lot harder

World of DTC Marketing

Health care professionals have been critical of these agencies’ decisions during the pandemic, with some concerned that their work has been politicized and now with advisory panel members resigning as a result of the terrible decision to approve Biogen’s drug you can bet that HCPs are going o want to see a lot more clinical data.

Marketing 187